                               SEQUENCE LISTING

<110> PORTAGE PHARMACEUTICALS LTD.
 
<120> USE OF CELL-PERMEABLE PEPTIDES AND NON-PEPTIDE CARRIERS 
      CONJUGATED WITH NEMO BINDING DOMAIN CARGO SEQUENCE FOR THE 
      TREATMENT OF DRY EYE DISEASE AND UVEITIS

<130> 89352-8005.WO00

<140>
<141>

<150> 62/329,540
<151> 2016-04-29

<160> 148   

<170> PatentIn version 3.5

<210> 1
<211> 11
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      NEMO binding domain (NBD) (second region peptide only)

<400> 1
Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
1               5                   10      


<210> 2
<211> 86
<212> PRT
<213> Human immunodeficiency virus

<400> 2
Met Glu Pro Val Asp Pro Arg Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Lys Thr Ala Cys Thr Asn Cys Tyr Cys Lys Lys Cys Cys Phe 
            20                  25                  30          


His Cys Gln Val Cys Phe Ile Thr Lys Ala Leu Gly Ile Ser Tyr Gly 
        35                  40                  45              


Arg Lys Lys Arg Arg Gln Arg Arg Arg Ala His Gln Asn Ser Gln Thr 
    50                  55                  60                  


His Gln Ala Ser Leu Ser Lys Gln Pro Thr Ser Gln Pro Arg Gly Asp 
65                  70                  75                  80  


Pro Thr Gly Pro Lys Glu 
                85      


<210> 3
<211> 11
<212> PRT
<213> Human immunodeficiency virus

<400> 3
Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210> 4
<211> 9
<212> PRT
<213> Human immunodeficiency virus

<400> 4
Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   


<210> 5
<211> 13
<212> PRT
<213> Human immunodeficiency virus

<400> 5
Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln 
1               5                   10              


<210> 6
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(13)
<223> D-amino acids

<400> 6
Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln 
1               5                   10              


<210> 7
<211> 12
<212> PRT
<213> Human immunodeficiency virus

<400> 7
Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln 
1               5                   10          


<210> 8
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Gly Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Pro Gln 
1               5                   10              


<210> 9
<211> 16
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Penetratin sequence

<400> 9
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210> 10
<211> 33
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      VP22 sequence

<400> 10
Asp Ala Ala Thr Ala Thr Arg Gly Arg Ser Ala Ala Ser Arg Pro Thr 
1               5                   10                  15      


Glu Arg Pro Arg Ala Pro Ala Arg Ser Ala Ser Arg Pro Arg Arg Val 
            20                  25                  30          


Asp 
    


<210> 11
<211> 18
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      pVEC sequence

<400> 11
Leu Leu Ile Ile Leu Arg Arg Arg Ile Arg Lys Gln Ala His Ala His 
1               5                   10                  15      


Ser Lys 
        


<210> 12
<211> 16
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      pISL sequence

<400> 12
Arg Val Ile Arg Val Trp Phe Gln Asn Lys Arg Cys Lys Asp Lys Lys 
1               5                   10                  15      


<210> 13
<211> 24
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      hCT (9-32) derived peptide

<400> 13
Leu Gly Thr Tyr Thr Gln Asp Phe Asn Lys Phe His Thr Phe Pro Gln 
1               5                   10                  15      


Thr Ala Ile Gly Val Gly Ala Pro 
            20                  


<210> 14
<211> 27
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Transportan (TP) sequence

<400> 14
Gly Trp Thr Leu Asn Ser Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu 
1               5                   10                  15      


Lys Ala Leu Ala Ala Leu Ala Lys Lys Ile Leu 
            20                  25          


<210> 15
<211> 21
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      TP10 sequence

<400> 15
Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu Lys Ala Leu Ala Ala Leu 
1               5                   10                  15      


Ala Lys Lys Ile Leu 
            20      


<210> 16
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (1)..(16)
<223> This sequence may encompass 4-16 residues

<400> 16
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


<210> 17
<211> 18
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      MAP sequence

<400> 17
Lys Leu Ala Leu Lys Leu Ala Leu Lys Ala Leu Lys Ala Ala Leu Lys 
1               5                   10                  15      


Leu Ala 
        


<210> 18
<211> 21
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Pep-1 sequence

<400> 18
Lys Glu Thr Trp Trp Glu Thr Trp Trp Thr Glu Trp Ser Gln Pro Lys 
1               5                   10                  15      


Lys Lys Arg Lys Val 
            20      


<210> 19
<211> 21
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Pep-2 sequence

<400> 19
Lys Glu Thr Trp Phe Glu Thr Trp Phe Thr Glu Trp Ser Gln Pro Lys 
1               5                   10                  15      


Lys Lys Arg Lys Val 
            20      


<210> 20
<211> 24
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      MPG sequence

<400> 20
Gly Ala Leu Phe Leu Gly Trp Leu Gly Ala Ala Gly Ser Thr Met Gly 
1               5                   10                  15      


Ala Pro Lys Lys Lys Arg Lys Val 
            20                  


<210> 21
<211> 30
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      KALA sequence

<400> 21
Trp Glu Ala Lys Leu Ala Lys Ala Leu Ala Lys Ala Leu Ala Lys His 
1               5                   10                  15      


Leu Ala Lys Ala Leu Ala Lys Ala Leu Lys Ala Cys Glu Ala 
            20                  25                  30  


<210> 22
<211> 20
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      ppTG1 sequence

<400> 22
Gly Leu Phe Lys Ala Leu Leu Lys Leu Leu Lys Ser Leu Trp Lys Leu 
1               5                   10                  15      


Leu Leu Lys Ala 
            20  


<210> 23
<211> 20
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      ppTG20 sequence

<400> 23
Gly Leu Phe Arg Ala Leu Leu Arg Leu Leu Arg Ser Leu Trp Arg Leu 
1               5                   10                  15      


Leu Leu Arg Ala 
            20  


<210> 24
<211> 11
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      PTD4 sequence

<400> 24
Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala 
1               5                   10      


<210> 25
<211> 14
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      PTD5 sequence

<400> 25
Arg Arg Gln Arg Arg Thr Ser Lys Leu Met Lys Arg Gly Gly 
1               5                   10                  


<210> 26
<211> 22
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      M-918 sequence

<400> 26
Met Val Thr Val Leu Phe Arg Arg Leu Arg Ile Arg Arg Ala Cys Gly 
1               5                   10                  15      


Pro Pro Arg Val Arg Val 
            20          


<210> 27
<211> 16
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      KNO sequence

<400> 27
Lys Gln Ile Asn Asn Trp Phe Ile Asn Gln Arg Lys Arg His Trp Lys 
1               5                   10                  15      


<210> 28
<211> 11
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Hph-1 sequence

<400> 28
Tyr Ala Arg Val Arg Arg Arg Gly Pro Arg Arg 
1               5                   10      


<210> 29
<211> 17
<212> PRT
<213> Human immunodeficiency virus

<400> 29
Thr Arg Gln Ala Arg Arg Asn Arg Arg Arg Arg Trp Arg Glu Arg Gln 
1               5                   10                  15      


Arg 
    


<210> 30
<211> 16
<212> PRT
<213> Drosophila sp.

<400> 30
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210> 31
<211> 35
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      POD sequence

<400> 31
Gly Gly Gly Ala Arg Lys Lys Ala Ala Lys Ala Ala Arg Lys Lys Ala 
1               5                   10                  15      


Ala Lys Ala Ala Arg Lys Lys Ala Ala Lys Ala Ala Arg Lys Lys Ala 
            20                  25                  30          


Ala Lys Ala 
        35  


<210> 32
<211> 20
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      S413-PV sequence

<400> 32
Ala Leu Trp Lys Thr Leu Leu Lys Lys Val Leu Lys Ala Pro Lys Lys 
1               5                   10                  15      


Lys Arg Lys Val 
            20  


<210> 33
<211> 13
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      S41 sequence

<400> 33
Cys Val Gln Trp Ser Leu Leu Arg Gly Tyr Gln Pro Cys 
1               5                   10              


<210> 34
<211> 20
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      KADY sequence

<400> 34
Gly Leu Trp Arg Ala Leu Trp Arg Leu Leu Arg Ser Leu Trp Arg Leu 
1               5                   10                  15      


Leu Trp Lys Ala 
            20  


<210> 35
<211> 28
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      P28 Azurin (50-77) sequence

<400> 35
Leu Ser Thr Ala Ala Asp Met Gln Gly Val Val Thr Asp Gly Met Ala 
1               5                   10                  15      


Ser Gly Leu Asp Lys Asp Tyr Leu Lys Pro Asp Asp 
            20                  25              


<210> 36
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      Vectocell peptide

<400> 36
Cys Val Lys Arg Gly Leu Lys Leu Arg His Val Arg Pro Arg Val Thr 
1               5                   10                  15      


Arg Met Asp Val 
            20  


<210> 37
<211> 7
<212> PRT
<213> Simian virus 40

<400> 37
Pro Lys Lys Lys Arg Lys Val 
1               5           


<210> 38
<211> 16
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Nucleoplasmin-NLS sequence

<400> 38
Lys Arg Pro Ala Ala Ile Lys Lys Ala Gly Gln Ala Lys Lys Lys Lys 
1               5                   10                  15      


<210> 39
<211> 15
<212> PRT
<213> Feline herpesvirus

<400> 39
Arg Arg Arg Arg Asn Arg Thr Arg Arg Asn Arg Arg Arg Val Arg 
1               5                   10                  15  


<210> 40
<211> 19
<212> PRT
<213> Brome mosaic virus

<400> 40
Lys Met Thr Arg Ala Gln Arg Arg Ala Ala Ala Arg Arg Asn Arg Trp 
1               5                   10                  15      


Thr Ala Arg 
            


<210> 41
<211> 13
<212> PRT
<213> Human T-lymphotropic virus

<400> 41
Thr Arg Arg Gln Arg Thr Arg Arg Ala Arg Arg Asn Ala 
1               5                   10              


<210> 42
<211> 19
<212> PRT
<213> Cowpea chlorotic mottle virus

<400> 42
Lys Leu Thr Arg Ala Gln Arg Arg Ala Ala Ala Arg Lys Asn Lys Arg 
1               5                   10                  15      


Asn Thr Arg 
            


<210> 43
<211> 17
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      P22 N (14-30) sequence

<400> 43
Asn Ala Lys Thr Arg Arg His Glu Arg Arg Arg Lys Leu Ala Ile Glu 
1               5                   10                  15      


Arg 
    


<210> 44
<211> 22
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Lamda N (1-22) sequence

<400> 44
Met Asp Ala Gln Thr Arg Arg Arg Glu Arg Arg Ala Glu Lys Gln Ala 
1               5                   10                  15      


Gln Trp Lys Ala Ala Asn 
            20          


<210> 45
<211> 18
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Phi-21 N (12-29) sequence

<400> 45
Thr Ala Lys Thr Arg Tyr Lys Ala Arg Arg Ala Glu Leu Ile Ala Glu 
1               5                   10                  15      


Arg Arg 
        


<210> 46
<211> 16
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Yeast PRP6 (129-144) sequence

<400> 46
Thr Arg Arg Asn Lys Arg Asn Arg Ile Gln Glu Gln Leu Asn Arg Lys 
1               5                   10                  15      


<210> 47
<211> 12
<212> PRT
<213> Homo sapiens

<400> 47
Ser Gln Met Thr Arg Gln Ala Arg Arg Leu Tyr Val 
1               5                   10          


<210> 48
<211> 26
<212> PRT
<213> Homo sapiens

<400> 48
Lys Arg Arg Ile Arg Arg Glu Arg Asn Lys Met Ala Ala Ala Lys Ser 
1               5                   10                  15      


Arg Asn Arg Arg Arg Glu Leu Thr Asp Thr 
            20                  25      


<210> 49
<211> 28
<212> PRT
<213> Homo sapiens

<400> 49
Arg Ile Lys Ala Glu Arg Lys Arg Met Arg Asn Arg Ile Ala Ala Ser 
1               5                   10                  15      


Lys Ser Arg Lys Arg Lys Leu Glu Arg Ile Ala Arg 
            20                  25              


<210> 50
<211> 22
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Yeast GCN4 sequence

<400> 50
Lys Arg Ala Arg Asn Thr Glu Ala Ala Arg Arg Ser Arg Ala Arg Lys 
1               5                   10                  15      


Leu Gln Arg Met Lys Gln 
            20          


<210> 51
<211> 16
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Pen-Arg sequence

<400> 51
Arg Gln Ile Arg Ile Trp Phe Gln Asn Arg Arg Met Arg Trp Arg Arg 
1               5                   10                  15      


<210> 52
<211> 17
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Dyn A sequence

<400> 52
Tyr Gly Gly Phe Leu Arg Arg Ile Arg Pro Lys Leu Lys Trp Asp Asn 
1               5                   10                  15      


Gln 
    


<210> 53
<211> 13
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Dyn B sequence

<400> 53
Tyr Gly Gly Phe Leu Arg Arg Gln Phe Lys Val Val Thr 
1               5                   10              


<210> 54
<211> 32
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Big Dyn sequence

<400> 54
Tyr Gly Gly Phe Leu Arg Arg Ile Arg Pro Lys Leu Lys Trp Asp Asn 
1               5                   10                  15      


Gln Lys Arg Tyr Gly Gly Phe Leu Arg Arg Gln Phe Lys Val Val Thr 
            20                  25                  30          


<210> 55
<211> 21
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Big Dyn 6-26 sequence

<400> 55
Arg Arg Ile Arg Pro Lys Leu Lys Trp Asp Asn Gln Lys Arg Tyr Gly 
1               5                   10                  15      


Gly Phe Leu Arg Arg 
            20      


<210> 56
<211> 28
<212> PRT
<213> Mus sp.

<400> 56
Met Ala Asn Leu Gly Tyr Trp Leu Leu Ala Leu Phe Val Thr Met Trp 
1               5                   10                  15      


Thr Asp Val Gly Leu Cys Lys Lys Arg Pro Lys Pro 
            20                  25              


<210> 57
<211> 28
<212> PRT
<213> Mus sp.

<400> 57
Met Leu Leu Ala Asp Cys Phe Pro Leu Thr Pro Gly Leu Asn Lys Val 
1               5                   10                  15      


Leu Trp Gly Thr Val Ala Lys Arg Trp Tyr Met Lys 
            20                  25              


<210> 58
<211> 12
<212> PRT
<213> Mus sp.

<400> 58
Val Gly Leu Cys Lys Lys Arg Pro Lys Pro Gly Gly 
1               5                   10          


<210> 59
<211> 6
<212> PRT
<213> Mus sp.

<400> 59
Lys Lys Arg Pro Lys Pro 
1               5       


<210> 60
<211> 28
<212> PRT
<213> Mus sp.

<400> 60
Lys Lys Arg Pro Lys Pro Gly Gly Trp Asn Thr Gly Gly Ser Arg Tyr 
1               5                   10                  15      


Pro Gly Gln Gly Ser Pro Gly Gly Asn Arg Tyr Pro 
            20                  25              


<210> 61
<211> 30
<212> PRT
<213> Bos sp.

<400> 61
Met Val Lys Ser Lys Ile Gly Ser Trp Ile Leu Val Leu Phe Val Ala 
1               5                   10                  15      


Met Trp Ser Asp Val Gly Leu Cys Lys Lys Arg Pro Lys Pro 
            20                  25                  30  


<210> 62
<211> 37
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      LL-37 sequence

<400> 62
Leu Leu Gly Asp Phe Phe Arg Lys Ser Lys Glu Lys Ile Gly Lys Glu 
1               5                   10                  15      


Phe Lys Arg Ile Val Gln Arg Ile Lys Asp Phe Leu Arg Asn Leu Val 
            20                  25                  30          


Pro Arg Thr Glu Ser 
        35          


<210> 63
<211> 23
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Magainin 2 sequence

<400> 63
Gly Ile Gly Lys Phe Leu His Ser Ala Lys Lys Phe Gly Lys Ala Phe 
1               5                   10                  15      


Val Gly Glu Ile Met Asn Ser 
            20              


<210> 64
<211> 21
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Buforin 2 sequence

<400> 64
Thr Arg Ser Ser Arg Ala Gly Leu Gln Phe Pro Val Gly Arg Val His 
1               5                   10                  15      


Arg Leu Leu Arg Lys 
            20      


<210> 65
<211> 14
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Apidaecins sequence


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Val or Ile

<400> 65
Arg Pro Xaa Tyr Ile Pro Gln Pro Arg Pro Pro His Pro Arg 
1               5                   10                  


<210> 66
<211> 97
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 66
Met Glu Pro Val Asp Pro Arg Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Lys Thr Ala Cys Thr Asn Cys Tyr Cys Lys Lys Cys Cys Phe 
            20                  25                  30          


His Cys Gln Val Cys Phe Ile Thr Lys Ala Leu Gly Ile Ser Tyr Gly 
        35                  40                  45              


Arg Lys Lys Arg Arg Gln Arg Arg Arg Ala His Gln Asn Ser Gln Thr 
    50                  55                  60                  


His Gln Ala Ser Leu Ser Lys Gln Pro Thr Ser Gln Pro Arg Gly Asp 
65                  70                  75                  80  


Pro Thr Gly Pro Lys Glu Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr 
                85                  90                  95      


Glu 
    


<210> 67
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 67
Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Thr Ala Leu Asp Trp 
1               5                   10                  15      


Ser Trp Leu Gln Thr Glu 
            20          


<210> 68
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 68
Arg Lys Lys Arg Arg Gln Arg Arg Arg Thr Ala Leu Asp Trp Ser Trp 
1               5                   10                  15      


Leu Gln Thr Glu 
            20  


<210> 69
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 69
Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Thr Ala Leu 
1               5                   10                  15      


Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  


<210> 70
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(13)
<223> D-amino acids

<400> 70
Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Thr Ala Leu 
1               5                   10                  15      


Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  


<210> 71
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 71
Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Thr Ala Leu Asp 
1               5                   10                  15      


Trp Ser Trp Leu Gln Thr Glu 
            20              


<210> 72
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 72
Gly Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Pro Gln Thr Ala Leu 
1               5                   10                  15      


Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  


<210> 73
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 73
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25          


<210> 74
<211> 44
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 74
Asp Ala Ala Thr Ala Thr Arg Gly Arg Ser Ala Ala Ser Arg Pro Thr 
1               5                   10                  15      


Glu Arg Pro Arg Ala Pro Ala Arg Ser Ala Ser Arg Pro Arg Arg Val 
            20                  25                  30          


Asp Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
        35                  40                  


<210> 75
<211> 29
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 75
Leu Leu Ile Ile Leu Arg Arg Arg Ile Arg Lys Gln Ala His Ala His 
1               5                   10                  15      


Ser Lys Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25                  


<210> 76
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 76
Arg Val Ile Arg Val Trp Phe Gln Asn Lys Arg Cys Lys Asp Lys Lys 
1               5                   10                  15      


Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25          


<210> 77
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 77
Leu Gly Thr Tyr Thr Gln Asp Phe Asn Lys Phe His Thr Phe Pro Gln 
1               5                   10                  15      


Thr Ala Ile Gly Val Gly Ala Pro Thr Ala Leu Asp Trp Ser Trp Leu 
            20                  25                  30          


Gln Thr Glu 
        35  


<210> 78
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 78
Gly Trp Thr Leu Asn Ser Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu 
1               5                   10                  15      


Lys Ala Leu Ala Ala Leu Ala Lys Lys Ile Leu Thr Ala Leu Asp Trp 
            20                  25                  30          


Ser Trp Leu Gln Thr Glu 
        35              


<210> 79
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 79
Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu Lys Ala Leu Ala Ala Leu 
1               5                   10                  15      


Ala Lys Lys Ile Leu Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25                  30          


<210> 80
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (1)..(16)
<223> This region may encompass 4-16 residues

<400> 80
Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10                  15      


Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25          


<210> 81
<211> 29
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 81
Lys Leu Ala Leu Lys Leu Ala Leu Lys Ala Leu Lys Ala Ala Leu Lys 
1               5                   10                  15      


Leu Ala Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25                  


<210> 82
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 82
Lys Glu Thr Trp Trp Glu Thr Trp Trp Thr Glu Trp Ser Gln Pro Lys 
1               5                   10                  15      


Lys Lys Arg Lys Val Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25                  30          


<210> 83
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 83
Lys Glu Thr Trp Phe Glu Thr Trp Phe Thr Glu Trp Ser Gln Pro Lys 
1               5                   10                  15      


Lys Lys Arg Lys Val Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25                  30          


<210> 84
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 84
Gly Ala Leu Phe Leu Gly Trp Leu Gly Ala Ala Gly Ser Thr Met Gly 
1               5                   10                  15      


Ala Pro Lys Lys Lys Arg Lys Val Thr Ala Leu Asp Trp Ser Trp Leu 
            20                  25                  30          


Gln Thr Glu 
        35  


<210> 85
<211> 41
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 85
Trp Glu Ala Lys Leu Ala Lys Ala Leu Ala Lys Ala Leu Ala Lys His 
1               5                   10                  15      


Leu Ala Lys Ala Leu Ala Lys Ala Leu Lys Ala Cys Glu Ala Thr Ala 
            20                  25                  30          


Leu Asp Trp Ser Trp Leu Gln Thr Glu 
        35                  40      


<210> 86
<211> 31
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 86
Gly Leu Phe Lys Ala Leu Leu Lys Leu Leu Lys Ser Leu Trp Lys Leu 
1               5                   10                  15      


Leu Leu Lys Ala Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25                  30      


<210> 87
<211> 31
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 87
Gly Leu Phe Arg Ala Leu Leu Arg Leu Leu Arg Ser Leu Trp Arg Leu 
1               5                   10                  15      


Leu Leu Arg Ala Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25                  30      


<210> 88
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 88
Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala Thr Ala Leu Asp Trp 
1               5                   10                  15      


Ser Trp Leu Gln Thr Glu 
            20          


<210> 89
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 89
Arg Arg Gln Arg Arg Thr Ser Lys Leu Met Lys Arg Gly Gly Thr Ala 
1               5                   10                  15      


Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25  


<210> 90
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 90
Met Val Thr Val Leu Phe Arg Arg Leu Arg Ile Arg Arg Ala Cys Gly 
1               5                   10                  15      


Pro Pro Arg Val Arg Val Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr 
            20                  25                  30          


Glu 
    


<210> 91
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 91
Lys Gln Ile Asn Asn Trp Phe Ile Asn Gln Arg Lys Arg His Trp Lys 
1               5                   10                  15      


Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25          


<210> 92
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 92
Tyr Ala Arg Val Arg Arg Arg Gly Pro Arg Arg Thr Ala Leu Asp Trp 
1               5                   10                  15      


Ser Trp Leu Gln Thr Glu 
            20          


<210> 93
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 93
Thr Arg Gln Ala Arg Arg Asn Arg Arg Arg Arg Trp Arg Glu Arg Gln 
1               5                   10                  15      


Arg Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25              


<210> 94
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 94
Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25          


<210> 95
<211> 46
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 95
Gly Gly Gly Ala Arg Lys Lys Ala Ala Lys Ala Ala Arg Lys Lys Ala 
1               5                   10                  15      


Ala Lys Ala Ala Arg Lys Lys Ala Ala Lys Ala Ala Arg Lys Lys Ala 
            20                  25                  30          


Ala Lys Ala Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
        35                  40                  45      


<210> 96
<211> 31
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 96
Ala Leu Trp Lys Thr Leu Leu Lys Lys Val Leu Lys Ala Pro Lys Lys 
1               5                   10                  15      


Lys Arg Lys Val Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25                  30      


<210> 97
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 97
Cys Val Gln Trp Ser Leu Leu Arg Gly Tyr Gln Pro Cys Thr Ala Leu 
1               5                   10                  15      


Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  


<210> 98
<211> 31
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 98
Gly Leu Trp Arg Ala Leu Trp Arg Leu Leu Arg Ser Leu Trp Arg Leu 
1               5                   10                  15      


Leu Trp Lys Ala Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25                  30      


<210> 99
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 99
Leu Ser Thr Ala Ala Asp Met Gln Gly Val Val Thr Asp Gly Met Ala 
1               5                   10                  15      


Ser Gly Leu Asp Lys Asp Tyr Leu Lys Pro Asp Asp Thr Ala Leu Asp 
            20                  25                  30          


Trp Ser Trp Leu Gln Thr Glu 
        35                  


<210> 100
<211> 31
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 100
Cys Val Lys Arg Gly Leu Lys Leu Arg His Val Arg Pro Arg Val Thr 
1               5                   10                  15      


Arg Met Asp Val Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25                  30      


<210> 101
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 101
Pro Lys Lys Lys Arg Lys Val Thr Ala Leu Asp Trp Ser Trp Leu Gln 
1               5                   10                  15      


Thr Glu 
        


<210> 102
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 102
Lys Arg Pro Ala Ala Ile Lys Lys Ala Gly Gln Ala Lys Lys Lys Lys 
1               5                   10                  15      


Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25          


<210> 103
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 103
Arg Arg Arg Arg Asn Arg Thr Arg Arg Asn Arg Arg Arg Val Arg Thr 
1               5                   10                  15      


Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25      


<210> 104
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 104
Lys Met Thr Arg Ala Gln Arg Arg Ala Ala Ala Arg Arg Asn Arg Trp 
1               5                   10                  15      


Thr Ala Arg Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25                  30  


<210> 105
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 105
Thr Arg Arg Gln Arg Thr Arg Arg Ala Arg Arg Asn Ala Thr Ala Leu 
1               5                   10                  15      


Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  


<210> 106
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 106
Lys Leu Thr Arg Ala Gln Arg Arg Ala Ala Ala Arg Lys Asn Lys Arg 
1               5                   10                  15      


Asn Thr Arg Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25                  30  


<210> 107
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 107
Asn Ala Lys Thr Arg Arg His Glu Arg Arg Arg Lys Leu Ala Ile Glu 
1               5                   10                  15      


Arg Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25              


<210> 108
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 108
Met Asp Ala Gln Thr Arg Arg Arg Glu Arg Arg Ala Glu Lys Gln Ala 
1               5                   10                  15      


Gln Trp Lys Ala Ala Asn Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr 
            20                  25                  30          


Glu 
    


<210> 109
<211> 29
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 109
Thr Ala Lys Thr Arg Tyr Lys Ala Arg Arg Ala Glu Leu Ile Ala Glu 
1               5                   10                  15      


Arg Arg Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25                  


<210> 110
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 110
Thr Arg Arg Asn Lys Arg Asn Arg Ile Gln Glu Gln Leu Asn Arg Lys 
1               5                   10                  15      


Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25          


<210> 111
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 111
Ser Gln Met Thr Arg Gln Ala Arg Arg Leu Tyr Val Thr Ala Leu Asp 
1               5                   10                  15      


Trp Ser Trp Leu Gln Thr Glu 
            20              


<210> 112
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 112
Lys Arg Arg Ile Arg Arg Glu Arg Asn Lys Met Ala Ala Ala Lys Ser 
1               5                   10                  15      


Arg Asn Arg Arg Arg Glu Leu Thr Asp Thr Thr Ala Leu Asp Trp Ser 
            20                  25                  30          


Trp Leu Gln Thr Glu 
        35          


<210> 113
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 113
Arg Ile Lys Ala Glu Arg Lys Arg Met Arg Asn Arg Ile Ala Ala Ser 
1               5                   10                  15      


Lys Ser Arg Lys Arg Lys Leu Glu Arg Ile Ala Arg Thr Ala Leu Asp 
            20                  25                  30          


Trp Ser Trp Leu Gln Thr Glu 
        35                  


<210> 114
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 114
Lys Arg Ala Arg Asn Thr Glu Ala Ala Arg Arg Ser Arg Ala Arg Lys 
1               5                   10                  15      


Leu Gln Arg Met Lys Gln Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr 
            20                  25                  30          


Glu 
    


<210> 115
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 115
Arg Gln Ile Arg Ile Trp Phe Gln Asn Arg Arg Met Arg Trp Arg Arg 
1               5                   10                  15      


Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25          


<210> 116
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 116
Tyr Gly Gly Phe Leu Arg Arg Ile Arg Pro Lys Leu Lys Trp Asp Asn 
1               5                   10                  15      


Gln Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25              


<210> 117
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 117
Tyr Gly Gly Phe Leu Arg Arg Gln Phe Lys Val Val Thr Thr Ala Leu 
1               5                   10                  15      


Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  


<210> 118
<211> 43
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 118
Tyr Gly Gly Phe Leu Arg Arg Ile Arg Pro Lys Leu Lys Trp Asp Asn 
1               5                   10                  15      


Gln Lys Arg Tyr Gly Gly Phe Leu Arg Arg Gln Phe Lys Val Val Thr 
            20                  25                  30          


Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
        35                  40              


<210> 119
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 119
Arg Arg Ile Arg Pro Lys Leu Lys Trp Asp Asn Gln Lys Arg Tyr Gly 
1               5                   10                  15      


Gly Phe Leu Arg Arg Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25                  30          


<210> 120
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 120
Met Ala Asn Leu Gly Tyr Trp Leu Leu Ala Leu Phe Val Thr Met Trp 
1               5                   10                  15      


Thr Asp Val Gly Leu Cys Lys Lys Arg Pro Lys Pro Thr Ala Leu Asp 
            20                  25                  30          


Trp Ser Trp Leu Gln Thr Glu 
        35                  


<210> 121
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 121
Met Leu Leu Ala Asp Cys Phe Pro Leu Thr Pro Gly Leu Asn Lys Val 
1               5                   10                  15      


Leu Trp Gly Thr Val Ala Lys Arg Trp Tyr Met Lys Thr Ala Leu Asp 
            20                  25                  30          


Trp Ser Trp Leu Gln Thr Glu 
        35                  


<210> 122
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 122
Val Gly Leu Cys Lys Lys Arg Pro Lys Pro Gly Gly Thr Ala Leu Asp 
1               5                   10                  15      


Trp Ser Trp Leu Gln Thr Glu 
            20              


<210> 123
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 123
Lys Lys Arg Pro Lys Pro Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr 
1               5                   10                  15      


Glu 
    


<210> 124
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 124
Lys Lys Arg Pro Lys Pro Gly Gly Trp Asn Thr Gly Gly Ser Arg Tyr 
1               5                   10                  15      


Pro Gly Gln Gly Ser Pro Gly Gly Asn Arg Tyr Pro Thr Ala Leu Asp 
            20                  25                  30          


Trp Ser Trp Leu Gln Thr Glu 
        35                  


<210> 125
<211> 41
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 125
Met Val Lys Ser Lys Ile Gly Ser Trp Ile Leu Val Leu Phe Val Ala 
1               5                   10                  15      


Met Trp Ser Asp Val Gly Leu Cys Lys Lys Arg Pro Lys Pro Thr Ala 
            20                  25                  30          


Leu Asp Trp Ser Trp Leu Gln Thr Glu 
        35                  40      


<210> 126
<211> 48
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 126
Leu Leu Gly Asp Phe Phe Arg Lys Ser Lys Glu Lys Ile Gly Lys Glu 
1               5                   10                  15      


Phe Lys Arg Ile Val Gln Arg Ile Lys Asp Phe Leu Arg Asn Leu Val 
            20                  25                  30          


Pro Arg Thr Glu Ser Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
        35                  40                  45              


<210> 127
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 127
Gly Ile Gly Lys Phe Leu His Ser Ala Lys Lys Phe Gly Lys Ala Phe 
1               5                   10                  15      


Val Gly Glu Ile Met Asn Ser Thr Ala Leu Asp Trp Ser Trp Leu Gln 
            20                  25                  30          


Thr Glu 
        


<210> 128
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 128
Thr Arg Ser Ser Arg Ala Gly Leu Gln Phe Pro Val Gly Arg Val His 
1               5                   10                  15      


Arg Leu Leu Arg Lys Thr Ala Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25                  30          


<210> 129
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Val or Ile

<400> 129
Arg Pro Xaa Tyr Ile Pro Gln Pro Arg Pro Pro His Pro Arg Thr Ala 
1               5                   10                  15      


Leu Asp Trp Ser Trp Leu Gln Thr Glu 
            20                  25  


<210> 130
<211> 71
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 130
Ala Arg Lys Lys Arg Lys Pro Tyr Thr Lys Gln Gln Ile Ala Glu Leu 
1               5                   10                  15      


Glu Asn Glu Phe Leu Val Asn Glu Phe Ile Asn Arg Gln Lys Arg Lys 
            20                  25                  30          


Glu Leu Ser Asn Arg Leu Asn Leu Ser Asp Gln Gln Val Lys Ile Trp 
        35                  40                  45              


Phe Gln Asn Arg Arg Met Lys Lys Lys Arg Val Val Thr Ala Leu Asp 
    50                  55                  60                  


Trp Ser Trp Leu Gln Thr Glu 
65                  70      


<210> 131
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (1)..(20)
<223> This sequence may encompass 1-4 "Gly Gly Gly Gly Ser"
      repeating units

<400> 131
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
1               5                   10                  15      


Gly Gly Gly Ser 
            20  


<210> 132
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (1)..(8)
<223> This sequence may encompass 6 or 8 residues

<400> 132
Gly Gly Gly Gly Gly Gly Gly Gly 
1               5               


<210> 133
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (1)..(15)
<223> This sequence may encompass 1-3 "Glu Ala Ala Ala Lys"
      repeating units

<400> 133
Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys 
1               5                   10                  15  


<210> 134
<211> 46
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 134
Ala Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys 
1               5                   10                  15      


Glu Ala Ala Ala Lys Ala Leu Glu Ala Glu Ala Ala Ala Lys Glu Ala 
            20                  25                  30          


Ala Ala Lys Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys Ala 
        35                  40                  45      


<210> 135
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 135
Pro Ala Pro Ala Pro 
1               5   


<210> 136
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 136
Ala Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys Ala 
1               5                   10          


<210> 137
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MISC_FEATURE
<222> (1)..(34)
<223> This sequence may encompass 5-17 "Ala Pro"
      repeating units

<400> 137
Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro 
1               5                   10                  15      


Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro 
            20                  25                  30          


Ala Pro 
        


<210> 138
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 138
Val Ser Gln Thr Ser Lys Leu Thr Arg Ala Glu Thr Val Phe Pro Asp 
1               5                   10                  15      


Val 
    


<210> 139
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 139
Pro Leu Gly Leu Trp Ala Cys 
1               5           


<210> 140
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 140
Arg Val Leu Ala Glu Ala 
1               5       


<210> 141
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 141
Glu Asp Val Val Cys Cys Ser Met Ser Tyr 
1               5                   10  


<210> 142
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 142
Gly Gly Ile Glu Gly Arg Gly Ser 
1               5               


<210> 143
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 143
Thr Arg His Arg Gln Pro Arg Gly Trp Glu 
1               5                   10  


<210> 144
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 144
Ala Gly Asn Arg Val Arg Arg Ser Val Gly 
1               5                   10  


<210> 145
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 145
Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   


<210> 146
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 146
Gly Phe Leu Gly 
1               


<210> 147
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 147
His His His His His His Gly Ser 
1               5               


<210> 148
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (1)..(9)
<223> This sequence may encompass 8-9 residues

<400> 148
Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   


